Published in Nutr Cancer on January 01, 2004
Minireview: Obesity and breast cancer: the estrogen connection. Endocrinology (2009) 2.57
Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy. Breast Cancer Res Treat (2009) 1.23
The multifactorial role of leptin in driving the breast cancer microenvironment. Nat Rev Endocrinol (2011) 1.21
Diet-induced obesity alters dendritic cell function in the presence and absence of tumor growth. J Immunol (2012) 0.97
Obesity and cancer: mechanistic insights from transdisciplinary studies. Endocr Relat Cancer (2015) 0.96
A surprising link between the energetics of ovariectomy-induced weight gain and mammary tumor progression in obese rats. Obesity (Silver Spring) (2009) 0.90
Effect of chronic and intermittent calorie restriction on serum adiponectin and leptin and mammary tumorigenesis. Cancer Prev Res (Phila) (2011) 0.89
Multifaceted leptin network: the molecular connection between obesity and breast cancer. J Mammary Gland Biol Neoplasia (2013) 0.88
The balance between leptin and adiponectin in the control of carcinogenesis - focus on mammary tumorigenesis. Biochimie (2012) 0.88
Pubertal high fat diet: effects on mammary cancer development. Breast Cancer Res (2013) 0.87
Deconvoluting the obesity and breast cancer link: secretome, soil and seed interactions. J Mammary Gland Biol Neoplasia (2013) 0.83
Mouse breast cancer model-dependent changes in metabolic syndrome-associated phenotypes caused by maternal dioxin exposure and dietary fat. Am J Physiol Endocrinol Metab (2008) 0.82
Growth and Progression of TRAMP Prostate Tumors in Relationship to Diet and Obesity. Prostate Cancer (2012) 0.82
Effects of chronic vs. intermittent calorie restriction on mammary tumor incidence and serum adiponectin and leptin levels in MMTV-TGF-α mice at different ages. Oncol Lett (2010) 0.82
Combination of physical activity, nutrition, or other metabolic factors and vaccine response. Front Biosci (2007) 0.80
Impact of obesity on development and progression of mammary tumors in preclinical models of breast cancer. J Mammary Gland Biol Neoplasia (2013) 0.79
Excess weight gain accelerates 1-methyl-1-nitrosourea-induced mammary carcinogenesis in a rat model of premenopausal breast cancer. Cancer Prev Res (Phila) (2014) 0.77
The Obesity-Breast Cancer Conundrum: An Analysis of the Issues. Int J Mol Sci (2016) 0.76
Pubertal and adult windows of susceptibility to a high animal fat diet in Trp53-null mammary tumorigenesis. Oncotarget (2016) 0.75
IgA nephropathy. N Engl J Med (2002) 5.85
Leptin--a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst (2002) 3.08
MCP-1 is up-regulated in unstressed and stressed HO-1 knockout mice: Pathophysiologic correlates. Kidney Int (2005) 2.25
Preserved oxygenation despite reduced blood flow in poststenotic kidneys in human atherosclerotic renal artery stenosis. Hypertension (2010) 2.17
Distinct renal injury in early atherosclerosis and renovascular disease. Circulation (2002) 2.01
Trastuzumab-induced HER reprogramming in "resistant" breast carcinoma cells. Cancer Res (2009) 1.98
Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis. Arterioscler Thromb Vasc Biol (2003) 1.91
Neoangiogenesis and the presence of progenitor cells in the venous limb of an arteriovenous fistula in the rat. Am J Physiol Renal Physiol (2007) 1.88
Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury. Am J Transplant (2003) 1.86
Predicting subsequent decline in kidney allograft function from early surveillance biopsies. Am J Transplant (2005) 1.79
Simvastatin abates development of renal fibrosis in experimental renovascular disease. J Hypertens (2008) 1.78
Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer. Biochim Biophys Acta (2008) 1.76
Podocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective study. Hypertension (2013) 1.76
Urinary podocyte excretion as a marker for preeclampsia. Am J Obstet Gynecol (2007) 1.75
Recurrent idiopathic membranous nephropathy: early diagnosis by protocol biopsies and treatment with anti-CD20 monoclonal antibodies. Am J Transplant (2009) 1.71
Antioxidant intervention blunts renal injury in experimental renovascular disease. J Am Soc Nephrol (2004) 1.70
Sclerostin alters serum vitamin D metabolite and fibroblast growth factor 23 concentrations and the urinary excretion of calcium. Proc Natl Acad Sci U S A (2013) 1.70
Serum insulin-like growth factor-I and mammary tumor development in ad libitum-fed, chronic calorie-restricted, and intermittent calorie-restricted MMTV-TGF-alpha mice. Cancer Prev Res (Phila) (2009) 1.63
Myeloproliferative neoplasms cause glomerulopathy. Kidney Int (2011) 1.62
Renal vein cytokine release as an index of renal parenchymal inflammation in chronic experimental renal artery stenosis. Nephrol Dial Transplant (2013) 1.56
Development and preliminary testing of a translational model of hepatocellular carcinoma for MR imaging and interventional oncologic investigations. J Vasc Interv Radiol (2012) 1.54
Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy. Nephrol Dial Transplant (2002) 1.52
The use of magnetic resonance to evaluate tissue oxygenation in renal artery stenosis. J Am Soc Nephrol (2008) 1.51
Adipose tissue-derived mesenchymal stem cells improve revascularization outcomes to restore renal function in swine atherosclerotic renal artery stenosis. Stem Cells (2012) 1.44
Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev (2003) 1.43
Involvement of RNA helicases p68 and p72 in colon cancer. Cancer Res (2007) 1.41
Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1/ETS-related protein 81. Cancer Res (2009) 1.39
Genetically obese MMTV-TGF-alpha/Lep(ob)Lep(ob) female mice do not develop mammary tumors. Breast Cancer Res Treat (2003) 1.39
Mechanisms of tissue injury in renal artery stenosis: ischemia and beyond. Prog Cardiovasc Dis (2009) 1.39
Sumoylation of p68 and p72 RNA helicases affects protein stability and transactivation potential. Biochemistry (2010) 1.38
Endothelial progenitor cells homing and renal repair in experimental renovascular disease. Stem Cells (2010) 1.38
Kidney allograft fibrosis and atrophy early after living donor transplantation. Am J Transplant (2005) 1.37
Glomerular expression of nephrin and synaptopodin, but not podocin, is decreased in kidney sections from women with preeclampsia. Nephrol Dial Transplant (2007) 1.37
Persistent kidney dysfunction in swine renal artery stenosis correlates with outer cortical microvascular remodeling. Am J Physiol Renal Physiol (2011) 1.35
Leptin receptor-deficient MMTV-TGF-alpha/Lepr(db)Lepr(db) female mice do not develop oncogene-induced mammary tumors. Exp Biol Med (Maywood) (2004) 1.31
Renal involvement in primary Sjögren's syndrome: a clinicopathologic study. Clin J Am Soc Nephrol (2009) 1.31
Inflammatory and injury signals released from the post-stenotic human kidney. Eur Heart J (2012) 1.30
Ischaemic nephropathy secondary to atherosclerotic renal artery stenosis: clinical and histopathological correlates. Nephrol Dial Transplant (2010) 1.28
Temporal analysis of signaling pathways activated in a murine model of two-kidney, one-clip hypertension. Am J Physiol Renal Physiol (2009) 1.27
Effects of high-fat diet and/or body weight on mammary tumor leptin and apoptosis signaling pathways in MMTV-TGF-alpha mice. Breast Cancer Res (2007) 1.25
MCP-1 contributes to arteriovenous fistula failure. J Am Soc Nephrol (2010) 1.23
Transgenic sickle mice are markedly sensitive to renal ischemia-reperfusion injury. Am J Pathol (2005) 1.22
PR-domain-containing Mds1-Evi1 is critical for long-term hematopoietic stem cell function. Blood (2011) 1.21
Pathways of renal fibrosis and modulation of matrix turnover in experimental hypercholesterolemia. Hypertension (2005) 1.20
Focal and segmental glomerulosclerosis and plasma cell proliferative disorders. Am J Kidney Dis (2005) 1.20
Ligand-independent oncogenic signaling by the epidermal growth factor receptor: v-ErbB as a paradigm. Exp Cell Res (2003) 1.19
Blood oxygen level-dependent magnetic resonance imaging identifies cortical hypoxia in severe renovascular disease. Hypertension (2011) 1.19
Lin28 regulates HER2 and promotes malignancy through multiple mechanisms. Cell Cycle (2012) 1.17
Increased venous proinflammatory gene expression and intimal hyperplasia in an aorto-caval fistula model in the rat. Am J Pathol (2003) 1.17
Renal hemodynamic, inflammatory, and apoptotic responses to lipopolysaccharide in HO-1-/- mice. Am J Pathol (2007) 1.16
Increased glomerular filtration rate in early metabolic syndrome is associated with renal adiposity and microvascular proliferation. Am J Physiol Renal Physiol (2011) 1.15
Characterization of a model of an arteriovenous fistula in the rat: the effect of L-NAME. Am J Pathol (2010) 1.15
Renal upregulation of HO-1 reduces albumin-driven MCP-1 production: implications for chronic kidney disease. Am J Physiol Renal Physiol (2006) 1.12
Elevated blood pressure and cardiac hypertrophy after ablation of the gly96/IEX-1 gene. J Appl Physiol (1985) (2005) 1.11
VEGF inhibition, hypertension, and renal toxicity. Curr Oncol Rep (2012) 1.10
Correlation of quantitative digital image analysis with the glomerular filtration rate in chronic allograft nephropathy. Am J Transplant (2004) 1.10
Genetic deficiency of Smad3 protects the kidneys from atrophy and interstitial fibrosis in 2K1C hypertension. Am J Physiol Renal Physiol (2012) 1.05
Weight-cycling decreases incidence and increases latency of mammary tumors to a greater extent than does chronic caloric restriction in mouse mammary tumor virus-transforming growth factor-alpha female mice. Cancer Epidemiol Biomarkers Prev (2002) 1.05
The EGF/ErbB receptor family and apoptosis. Growth Factors (2002) 1.04
ABO-incompatible kidney transplantation using both A2 and non-A2 living donors. Transplantation (2003) 1.04
TGF expression and macrophage accumulation in atherosclerotic renal artery stenosis. Clin J Am Soc Nephrol (2012) 1.04
Endothelial outgrowth cells shift macrophage phenotype and improve kidney viability in swine renal artery stenosis. Arterioscler Thromb Vasc Biol (2013) 1.04
Intermittent calorie restriction delays prostate tumor detection and increases survival time in TRAMP mice. Nutr Cancer (2009) 1.04
LPS-induced murine systemic inflammation is driven by parenchymal cell activation and exclusively predicted by early MCP-1 plasma levels. Am J Pathol (2011) 1.04
Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease. Exp Biol Med (Maywood) (2007) 1.03
Primary trastuzumab resistance: new tricks for an old drug. Ann N Y Acad Sci (2010) 1.03
Enhanced renal cortical vascularization in experimental hypercholesterolemia. Kidney Int (2002) 1.03
Shedding of epidermal growth factor receptor is a regulated process that occurs with overexpression in malignant cells. Exp Cell Res (2008) 1.02
Transforming growth factor-beta signal transduction and progressive renal disease. Exp Biol Med (Maywood) (2002) 1.01
Genetic deficiency of Smad3 protects against murine ischemic acute kidney injury. Am J Physiol Renal Physiol (2011) 1.01
Histologic findings of antibody-mediated rejection in ABO blood-group-incompatible living-donor kidney transplantation. Am J Transplant (2004) 1.01
Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev (2005) 1.01
Effects of intermittent and chronic calorie restriction on mammalian target of rapamycin (mTOR) and IGF-I signaling pathways in mammary fat pad tissues and mammary tumors. Nutr Cancer (2011) 1.00
Prevention of mammary tumorigenesis by intermittent caloric restriction: does caloric intake during refeeding modulate the response? Exp Biol Med (Maywood) (2007) 1.00
Diet-induced obesity and mammary tumor development in relation to estrogen receptor status. Cancer Lett (2007) 0.99
Elevated fibroblast growth factor 23 in women with malignant ovarian tumors. Mayo Clin Proc (2005) 0.99
Lin28 regulates BMP4 and functions with Oct4 to affect ovarian tumor microenvironment. Cell Cycle (2012) 0.99
Age sensitizes the kidney to heme protein-induced acute kidney injury. Am J Physiol Renal Physiol (2012) 0.98
A chromosomal region 7p11.2 transcript map: its development and application to the study of EGFR amplicons in glioblastoma. Neuro Oncol (2002) 0.98
TGF-beta1 stimulates monocyte chemoattractant protein-1 expression in mesangial cells through a phosphodiesterase isoenzyme 4-dependent process. Am J Physiol Cell Physiol (2005) 0.98
EGFR isoforms and gene regulation in human endometrial cancer cells. Mol Cancer (2010) 0.97
Characterization and expression of novel 60-kDa and 110-kDa EGFR isoforms in human placenta. Ann N Y Acad Sci (2003) 0.97
Clinical implementation of soluble EGFR (sEGFR) as a theragnostic serum biomarker of breast, lung and ovarian cancer. IDrugs (2009) 0.97
Molecular evidence of injury and inflammation in normal and fibrotic renal allografts one year posttransplant. Transplantation (2007) 0.96
Cross-sectional analysis of intermittent versus chronic caloric restriction in the TRAMP mouse. Prostate (2009) 0.95
Chronic exposure to staphylococcal superantigen elicits a systemic inflammatory disease mimicking lupus. J Immunol (2012) 0.94
Serum soluble epidermal growth factor receptor concentrations decrease in postmenopausal metastatic breast cancer patients treated with letrozole. Cancer Res (2005) 0.94
Association of filtered sodium load with medullary volumes and medullary hypoxia in hypertensive African Americans as compared with whites. Am J Kidney Dis (2011) 0.94
Subclinical rejection in tacrolimus-treated renal transplant recipients. Transplantation (2002) 0.94
Amphiregulin expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 93 cases. Prostate (2004) 0.94